Elvia J. Osorio, PhD

Biography

EDUCATION

• 2014 PhD Degree, Department of Immunology and Pathogenesis, Ministry of Health. Instituto Oswaldo Cruz (IOC), FIOCRUZ. RJ. Brazil
• 2000 Master of Science, Department of Immunology, Ministry of Health. Instituto Oswaldo Cruz (IOC), FIOCRUZ. RJ. Brazil
• 1992 Bachelor of Science, University of Valle. Cali, Colombia

Dr. Osorio's research career has focused on the study of the role of myeloid cells in the immunopathogenesis of leishmaniasis, malnutrition, and the field of drug discovery. She is passionate about the development of molecular medicine approaches involving stem cell biology and molecular biology to alleviate disease. Dr. Osorio joined the University of Texas System, after held fellowships for postgraduate studies awarded by COLCIENCIAS (the Colombian Ministry of Science, Technology, and Innovation) and CNPq (National Council of Technological Development of Brazil). She has participated in more than twenty-two collaborative research projects funded by NIH (R01, R021), ICIDR, TMRC, Fulbright Foundation, IDRC of Canada and the Welcome Trust foundation. The US Department of Defense funded her participation in research initiatives to identify novel anti-leishmanial compounds using novel ex vivo experimental models, work recognized with the award of “Best Research in Medicine” at the University of Texas at San Antonio, TX. Her scientific work involves the development of experimental approaches using cutting-edge technologies in flow cytometry, molecular biology, and multiomics data interpretation to pinpoint mechanisms of disease and drug resistance. Her contribution to science has been published in more than thirty-four publications in peer reviewed journals and has been a consultant and laboratory trainer of more than twenty-eight pre-graduate students and post-docs. Dr. Osorio is currently a Research Scientist working in the development of an ex vivo screening system for precision medicine to treat residual and recurrent acute myeloid leukemia.